top of page


March 2024 Newsletter: Women's History Month Edition
Hello friends and colleagues, As we reflect on Women’s History Month, we would like to take the opportunity to shine a spotlight on...
Jun 14, 2024


February 2024 Newsletter: Leap Day Edition
Hello friends and colleagues, As we close out a short month packed with major updates and announcements, we are using this Leap Day to...
Jun 14, 2024


January 2024 Newsletter
Greetings friends and colleagues, Happy New Year and welcome to our first newsletter of 2024! As we usher in another promising year, we...
Jun 14, 2024


Prioritizing R&D Initiatives in Today’s Market
Dear Readers, As our economy continues to change, we thought it would be helpful to share some insights and industry patterns that we...
Dec 12, 2022


Our Approach to Storytelling
Dear friends and colleagues, “Biotech’s flameout,” “bloodbath,” “thousands of layoffs.” We’ve all heard it, and we’re in it. Whether...
Sep 12, 2022


5 Must-Have Slides for Investor Pitch Decks
To help our readers prepare for their next financing round, we’ve compiled a list of the 5 must-have slides for any investor pitch deck....
Jul 29, 2022


Tips for Navigating a Conference
Dear Readers, As we gear up for conference season, we thought it could be helpful to share some tips on how to succeed while at a...
Jul 29, 2022


Developments in Ulcerative Colitis
Many of our clients are pursuing groundbreaking therapies in disease areas with high unmet medical needs, giving our firm the chance to...
Dec 8, 2021


Top 5 uncertainties we tackle when creating revenue forecast models
One of our most sought-after commercial strategy services is the creation of revenue forecasts. As such, we’ve spent numerous projects...
Aug 5, 2021


Recent advances in antisense oligonucleotide therapy development
Our work at Headland covers a wide range of diseases and therapeutic areas, and we try to stay abreast of recent news and developments in...
May 26, 2021


The mystery of risk-taking in biotech (US, Japan)
As we’ve expanded our US-Japan services, we are often asked about the differences between the US and Japanese biopharma industry. There...
Dec 23, 2020


BIO 2020 Highlights
Last month we attended the first completely virtual BIO conference. We met with many innovative companies and are looking forward to...
Aug 7, 2020


Initiative on Racial Justice and Equality
A note from our CEO, President, and Founder: My team and I are deeply troubled by the ongoing examples of violence, cruelty, and...
Aug 7, 2020
bottom of page